Increasing awareness of various health-related disorders, increasing incidence of chronic and lifestyle disorders, high prevalence of infectious diseases such as HIV and hepatitis among women worldwide, increasing adoption of POC diagnostic tests and increasing number of diagnoses Imaging Centers support the growth of the market

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901

The global women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.

The prenatal genetic screening & carrier testing segment is expected to grow at the highest CAGR during the forecast period

Based on application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.

The hospitals & clinics segment is expected to account for the largest share of the women’s health diagnostics market

Based on end user, the women’s health diagnostics market is segmented into hospitals & clinics, diagnostic & imaging centers, and home care settings. The hospitals & clinics segment accounted for the largest share of the women’s health diagnostics market

Asia Pacific is expected to account for the highest CAGR for players operating in the women’s health diagnostics market

The Asia Pacific women’s health diagnostics market is expected to grow at the highest CAGR from 2020 to 2025. Improving healthcare infrastructures, growing per capita incomes, and the rising focus of key market companies in this region are major factors driving the growth of the APAC women’s health diagnostics market.

The prominent players in this market are Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Abbott Laboratories (US), Siemens AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), and Becton, Dickinson and Company (US).

Get 10% Free Customization on this Report @   https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=128928901

Market Segmentation

The study categorizes the Women’s Health Diagnostics Market based on application, end user, and regional and global level.

Global Women’s Health Diagnostics Market, by Application

  • Osteoporosis Testing
  • OVC Testing
    • OVC Tumor Marker Tests
    • OVC Diagnostic Imaging Tests
    • Other OVC Tests
  • Cervical Cancer Testing
    • Pap Smears
    • HPV Testing
  • Breast Cancer Testing
    • Mammography
    • Breast Cancer Tumor Marker Tests
    • Biopsies
    • Other Breast Cancer Tests
  • Pregnancy & Fertility Testing
    • Lab-based Testing
    • Pregnancy Testing & Ovulation Prediction Kits
    • Fertility Monitors
  • Prenatal Genetic Screening & Carrier Testing
    • CF Testing
    • Down’s Syndrome and Edwards’ Syndrome Testing
    • TORCH Testing
    • Other Prenatal Genetic Disease Tests
  • Infectious Disease Testing
    • MRSA Testing
    • UTI Testing
    • Hepatitis Testing
    • Tuberculosis Testing
    • Other Infectious Disease Tests
  • STD Testing
    • CT/NG Testing
    • HIV Testing
    • Other STD Tests
  • Ultrasound Tests

Global Women’s Health Diagnostics Market, by End User

  • Hospitals & Clinics
  • Diagnostic and Imaging Centers
  • Home Care Settings

Global Women’s Health Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
  • Middle East & Africa